The Estimated Impact of Implementing a Funding Allocation Formula on the Number of Gonorrhea Cases in the United States, 2014 to 2018.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
11
6
2021
medline:
3
11
2021
entrez:
10
6
2021
Statut:
ppublish
Résumé
The Centers for Disease Control and Prevention (CDC) allocates funds annually to state and local programs in the United States to monitor and prevent sexually transmitted diseases (STDs). In 2014, a funding formula was implemented to allocate prevention funds to jurisdictions according to their STD burden and population size. We estimated the effect of implementing the funding formula in terms of gonorrhea cases averted from 2014 to 2018, a period during which inflation-adjusted CDC STD prevention funding declined. Our model assumed that STD prevention funds have a measurable effect on subsequent reported gonorrhea case rates, and the magnitude of this effect was as estimated in an empirical analysis of decades of state-level gonorrhea rates. In applying this equation-based model, we assumed all factors affecting jurisdictions' gonorrhea rates were constant over time except for their STD prevention funding allocations. We used data on CDC STD prevention funding allocated to each jurisdiction over time. We estimated gonorrhea rates under the "funding formula" scenario compared with a hypothetical "status quo" funding scenario, which reflected traditional methods to allocate prevention funds. In the model, gonorrhea cases increased from 2014 to 2018 by approximately 6% because of a decline in prevention funding, regardless of how funds were allocated. However, the estimated increase in gonorrhea cases was 5222 (range, 1181-9195) cases less in the funding formula scenario than in the status quo scenario. By shifting resources toward jurisdictions with greater disease burden, the funding formula averted a substantial number of gonorrhea cases at no additional cost.
Sections du résumé
BACKGROUND
The Centers for Disease Control and Prevention (CDC) allocates funds annually to state and local programs in the United States to monitor and prevent sexually transmitted diseases (STDs). In 2014, a funding formula was implemented to allocate prevention funds to jurisdictions according to their STD burden and population size. We estimated the effect of implementing the funding formula in terms of gonorrhea cases averted from 2014 to 2018, a period during which inflation-adjusted CDC STD prevention funding declined.
METHODS
Our model assumed that STD prevention funds have a measurable effect on subsequent reported gonorrhea case rates, and the magnitude of this effect was as estimated in an empirical analysis of decades of state-level gonorrhea rates. In applying this equation-based model, we assumed all factors affecting jurisdictions' gonorrhea rates were constant over time except for their STD prevention funding allocations. We used data on CDC STD prevention funding allocated to each jurisdiction over time. We estimated gonorrhea rates under the "funding formula" scenario compared with a hypothetical "status quo" funding scenario, which reflected traditional methods to allocate prevention funds.
RESULTS
In the model, gonorrhea cases increased from 2014 to 2018 by approximately 6% because of a decline in prevention funding, regardless of how funds were allocated. However, the estimated increase in gonorrhea cases was 5222 (range, 1181-9195) cases less in the funding formula scenario than in the status quo scenario.
CONCLUSIONS
By shifting resources toward jurisdictions with greater disease burden, the funding formula averted a substantial number of gonorrhea cases at no additional cost.
Identifiants
pubmed: 34110755
pii: 00007435-202109000-00009
doi: 10.1097/OLQ.0000000000001398
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
663-669Informations de copyright
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest and Sources of Funding: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The authors received no financial support for the research, authorship, and/or publication of this article.
Références
CDC. The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Spotlight on CDC's STD Prevention Work. Available at: https://www.cdc.gov/std/dstdp/dstdp-stakeholder-report-design_inhouse-print.pdf . Accessed January 4, 2021.
Williams AM, Chesson HW. Recent changes in prevention funding to areas with high racial and ethnic disparities in sexually transmitted disease rates. Sex Transm Dis 2018; 45:703–705.
Benjamin G, Kizer K, Pane G, et al. The impact of sexually transmitted diseases on the United States: Still hidden, getting worse, can be controlled. A report by a panel of the National Academy of Public Administration. 2018.
Bolan G, Chesson H. Sexually transmitted diseases (STDs). 2012. Data & Statistics—Archive. Available at: https://www.cdc.gov/std/statistics/archive.htm . Accessed January 4, 2021.
Martin EG, Keenan PS. Sticky dollars: Inertia in the evolution of federal allocations for HIV care through the Ryan White HIV/AIDS program. Publius 2011; 41:101–125.
Buehler JW, Holtgrave DR. Challenges in defining an optimal approach to formula-based allocations of public health funds in the United States. BMC Public Health 2007; 7:44.
Ogden LL, Sellers K, Sammartino C, et al. Funding formulas for public health allocations: Federal and state strategies. J Public Health Manag Pract 2012; 18:309–316.
Williams AM, Kreisel K, Chesson HW. Impacts of federal prevention funding on reported gonorrhea and chlamydia rates. Am J Prev Med 2019; 56:352–358.
Chesson HW, Harrison P, Scotton CR, et al. Does funding for HIV and sexually transmitted disease prevention matter? Evidence from panel data. Eval Rev 2005; 29:3–23.
Chesson HW, Owusu-Edusei K. Examining the impact of federally-funded syphilis elimination activities in the USA. Soc Sci Med 2008; 67:2059–2062.
Gallet CA. The impact of public health spending on California STD rates. Int Adv Econ Res 2017; 23:149–159.
Chesson HW. Estimated effectiveness and cost-effectiveness of federally funded prevention efforts on gonorrhea rates in the United States, 1971–2003, under various assumptions about the impact of prevention funding. Sex Transm Dis 2006; 33:S140–S144.
Chesson HW, Ludovic JA, Berruti AA, et al. Methods for sexually transmitted disease prevention programs to estimate the health and medical cost impact of changes in their budget. J Sex Transm Dis 2018; 45:2–7.
Chesson HW, Owusu-Edusei K. Relative impact of different strategies for allocating federal funds for syphilis prevention. Sex Transm Dis 2018; 45:S72–S77.
CDC. Sexually Transmitted Disease Surveillance 2018: Tables. Available at: https://www.cdc.gov/std/stats18/tables/1.htm . Accessed January 4, 2021.
Leichliter JS, Heyer K, Peterman TA, et al. US public sexually transmitted disease clinical services in an era of declining public health funding: 2013–14. Sex Transm Dis 2017; 44:505–509.
CDC. The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. AtlasPlus. Available at: https://www.cdc.gov/nchhstp/Atlas/ . Accessed January10, 2021.
U.S. Bureau of the Census. State population totals and components of change: 2010–2019. Annual estimates of the resident population for the United States, Regions, States, and Puerto Rico: April 1, 2010 to July 1, 2019. Available at: https://www.census.gov/data/tables/time-series/demo/popest/2010s-state-total.html . Accessed June 6, 2020.
HHS. Congressional justifications of estimates for appropriations committees. 2021. Centers for Disease Control and Prevention (CDC). Available at: https://www.cdc.gov/budget/congressional-justifications/index.html . Accessed November 24, 2020.
U.S. Department of Labor. Consumer Price Indexes—All Urban Consumers, 1913–2019. Washington, DC: Bureau of Labor Statistics, United States Department of Labor 2020. Available at: https://www.usinflationcalculator.com/inflation/consumer-price-index-and-annual-percent-changes-from-1913-to-2008/ . Accessed June 1, 2020.
CDC. New CDC Report: STDs Continue to Rise in the U.S. 2019. Available at: https://www.cdc.gov/nchhstp/newsroom/2019/2018-STD-surveillance-report-press-release.html . Accessed July 1, 2020.